These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 23295930

  • 1. Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients.
    Wu K, Yau YC, Matukas L, Waters V.
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1546-8. PubMed ID: 23295930
    [Abstract] [Full Text] [Related]

  • 2. In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients.
    Ratjen A, Yau Y, Wettlaufer J, Matukas L, Zlosnik JE, Speert DP, LiPuma JJ, Tullis E, Waters V.
    Antimicrob Agents Chemother; 2015 Jan; 59(1):711-3. PubMed ID: 25348526
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression.
    Pompilio A, Crocetta V, Verginelli F, Di Bonaventura G.
    FEMS Microbiol Lett; 2016 Jul; 363(14):. PubMed ID: 27242375
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
    Cantón R, Valdezate S, Vindel A, Sánchez Del Saz B, Maíz L, Baquero F.
    Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
    [Abstract] [Full Text] [Related]

  • 5. Biofilm Eradication of Stenotrophomonas maltophilia by Levofloxacin and Trimethoprim-Sulfamethoxazole.
    Río-Chacón JMD, Rojas-Larios F, Bocanegra-Ibarias P, Salas-Treviño D, Espinoza-Gómez F, Camacho-Ortiz A, Flores-Treviño S.
    Jpn J Infect Dis; 2024 Jul 23; 77(4):213-219. PubMed ID: 38296539
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Temperature, pH and Trimethoprim-Sulfamethoxazole Are Potent Inhibitors of Biofilm Formation by Stenotrophomonas maltophilia Clinical Isolates.
    Biočanin M, Madi H, Vasiljević Z, Kojić M, Jovčić B, Lozo J.
    Pol J Microbiol; 2017 Dec 04; 66(4):433-438. PubMed ID: 29319523
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm.
    Pollini S, Di Pilato V, Landini G, Di Maggio T, Cannatelli A, Sottotetti S, Cariani L, Aliberti S, Blasi F, Sergio F, Rossolini GM, Pallecchi L.
    PLoS One; 2018 Dec 04; 13(10):e0203941. PubMed ID: 30273348
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms.
    Sun E, Liang G, Wang L, Wei W, Lei M, Song S, Han R, Wang Y, Qi W.
    Braz J Infect Dis; 2016 Dec 04; 20(4):365-73. PubMed ID: 27183359
    [Abstract] [Full Text] [Related]

  • 13. Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients.
    Wang CH, Yu CM, Hsu ST, Wu RX.
    J Hosp Infect; 2020 Jan 04; 104(1):46-52. PubMed ID: 31505224
    [Abstract] [Full Text] [Related]

  • 14. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
    Duan Z, Qin J, Liu Y, Li C, Ying C.
    BMC Microbiol; 2020 Sep 29; 20(1):294. PubMed ID: 32993493
    [Abstract] [Full Text] [Related]

  • 15. Combination antimicrobial susceptibility testing of multidrug-resistant Stenotrophomonas maltophilia from cystic fibrosis patients.
    Milne KE, Gould IM.
    Antimicrob Agents Chemother; 2012 Aug 29; 56(8):4071-7. PubMed ID: 22585220
    [Abstract] [Full Text] [Related]

  • 16. Antibiotic susceptibility of Stenotrophomonas maltophilia in the presence of lactoferrin.
    Qamruddin AO, Alkawash MA, Soothill JS.
    Antimicrob Agents Chemother; 2005 Oct 29; 49(10):4425-6. PubMed ID: 16189141
    [No Abstract] [Full Text] [Related]

  • 17. Effect of antimicrobials on Stenotrophomonas maltophilia biofilm.
    Santos Carvalhais BE, Souza E Silva C, Dos Santos KV.
    Future Microbiol; 2021 Jan 29; 16(2):83-93. PubMed ID: 33470844
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of colistin susceptibility in multidrug-resistant clinical isolates from cystic fibrosis, France.
    Biswas S, Dubus JC, Reynaud-Gaubert M, Stremler N, Rolain JM.
    Eur J Clin Microbiol Infect Dis; 2013 Nov 29; 32(11):1461-4. PubMed ID: 23719852
    [Abstract] [Full Text] [Related]

  • 19. Characterization of small-colony-variant Stenotrophomonas maltophilia isolated from the sputum specimens of five patients with cystic fibrosis.
    Anderson SW, Stapp JR, Burns JL, Qin X.
    J Clin Microbiol; 2007 Feb 29; 45(2):529-35. PubMed ID: 17135443
    [Abstract] [Full Text] [Related]

  • 20. Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections.
    Passerini de Rossi B, García C, Calenda M, Vay C, Franco M.
    Int J Antimicrob Agents; 2009 Sep 29; 34(3):260-4. PubMed ID: 19362452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.